GlassScriptPhysician profile
Mark S Katsma
NPI 1326571969
$9,428.15
in general payments reported to CMS, 2019-2025
10 companies · $4,804 in 2025
The $4,804 reported for 2025 was more than what 86% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,614 · 2021: $1,350 · 2022: $635 · 2024: $24.38 · 2025: $4,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,295 · Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,294.63 |
| Food and Beverage | $534.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smaio USA Corporation | $4,710.65 | 2025 | |
| Fortis Surgical, LLC | $2,614.00 | 2020 | |
| Medical Device Business Services, INC. | $1,350.00 | 2021 | |
| Depuy Synthes Sales INC. | $201.06 | 2022 | |
| Zimvie INC. | $188.21 | 2022 | |
| Orthopediatrics Corp. | $135.85 | 2022 | |
| Biocomposites INC | $110.35 | 2022 | |
| Stryker Corporation | $52.51 | 2024-2025 | Cinchlock, Hipcheck |
| Orthofix Medical, INC. | $47.05 | 2025 | Explorer To |
| Elevate Surgical Co | $18.47 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Katsma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.